vs
Amarin Corp plc（AMRN）与牛津地产（IIPR）财务数据对比。点击上方公司名可切换其他公司
牛津地产的季度营收约是Amarin Corp plc的1.5倍（$66.7M vs $45.1M），牛津地产净利率更高（47.8% vs -23.3%，领先71.1%），Amarin Corp plc同比增速更快（7.0% vs -13.1%），过去两年牛津地产的营收复合增速更高（-6.0% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
牛津地产是一家加拿大跨国企业，业务涵盖房地产投资、开发与物业管理。其投资组合包含写字楼、零售、工业、多户住宅、生命科学及酒店类资产。该公司1960年以私营企业形式创立，自2003年起成为安大略省市政雇员退休系统（OMERS）的全资子公司，总部设于多伦多，在纽约、伦敦、澳大利亚、新加坡及卢森堡均设有区域总部。
AMRN vs IIPR — 直观对比
营收规模更大
IIPR
是对方的1.5倍
$45.1M
营收增速更快
AMRN
高出20.1%
-13.1%
净利率更高
IIPR
高出71.1%
-23.3%
两年增速更快
IIPR
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $66.7M |
| 净利润 | $-10.5M | $31.8M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 47.8% |
| 净利率 | -23.3% | 47.8% |
| 营收同比 | 7.0% | -13.1% |
| 净利润同比 | 33.0% | -20.4% |
| 每股收益（稀释后） | — | $1.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNIIPR
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $66.7M | ||
| Q3 25 | $49.7M | $64.7M | ||
| Q2 25 | $72.7M | $62.9M | ||
| Q1 25 | $42.0M | $71.7M | ||
| Q4 24 | $62.3M | $76.7M | ||
| Q3 24 | $42.3M | $76.5M | ||
| Q2 24 | $67.5M | $79.8M |
净利润AMRNIIPR
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $31.8M | ||
| Q3 25 | $-7.7M | $29.3M | ||
| Q2 25 | $-14.1M | $26.0M | ||
| Q1 25 | $-15.7M | $31.1M | ||
| Q4 24 | $-48.6M | $40.0M | ||
| Q3 24 | $-25.1M | $40.2M | ||
| Q2 24 | $1.5M | $42.0M |
毛利率AMRNIIPR
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNIIPR
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 47.8% | ||
| Q3 25 | -22.4% | 45.5% | ||
| Q2 25 | -22.0% | 45.9% | ||
| Q1 25 | -39.9% | 47.4% | ||
| Q4 24 | -84.3% | 54.7% | ||
| Q3 24 | -59.5% | 54.8% | ||
| Q2 24 | -0.8% | 53.1% |
净利率AMRNIIPR
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 47.8% | ||
| Q3 25 | -15.6% | 45.3% | ||
| Q2 25 | -19.4% | 41.4% | ||
| Q1 25 | -37.4% | 43.3% | ||
| Q4 24 | -78.0% | 52.2% | ||
| Q3 24 | -59.4% | 52.6% | ||
| Q2 24 | 2.3% | 52.6% |
每股收益（稀释后）AMRNIIPR
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $1.07 | ||
| Q3 25 | $-0.02 | $0.97 | ||
| Q2 25 | $-0.03 | $0.86 | ||
| Q1 25 | $-0.04 | $1.03 | ||
| Q4 24 | $-0.12 | $1.35 | ||
| Q3 24 | $-0.06 | $1.37 | ||
| Q2 24 | $0.00 | $1.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $47.6M |
| 总债务越低越好 | — | $393.7M |
| 股东权益账面价值 | — | $1.8B |
| 总资产 | $645.8M | $2.4B |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资AMRNIIPR
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $47.6M | ||
| Q3 25 | $286.6M | $41.9M | ||
| Q2 25 | $298.7M | $104.9M | ||
| Q1 25 | $281.8M | $133.3M | ||
| Q4 24 | $294.2M | $151.2M | ||
| Q3 24 | $305.7M | $172.4M | ||
| Q2 24 | $306.7M | $160.9M |
总债务AMRNIIPR
| Q1 26 | — | — | ||
| Q4 25 | — | $393.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AMRNIIPR
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $1.8B | ||
| Q3 25 | $458.9M | $1.9B | ||
| Q2 25 | $464.9M | $1.9B | ||
| Q1 25 | $473.7M | $1.9B | ||
| Q4 24 | $486.2M | $1.9B | ||
| Q3 24 | $531.4M | $1.9B | ||
| Q2 24 | $551.9M | $1.9B |
总资产AMRNIIPR
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $2.4B | ||
| Q3 25 | $659.8M | $2.3B | ||
| Q2 25 | $670.1M | $2.3B | ||
| Q1 25 | $655.7M | $2.4B | ||
| Q4 24 | $685.3M | $2.4B | ||
| Q3 24 | $750.6M | $2.4B | ||
| Q2 24 | $799.9M | $2.4B |
负债/权益比AMRNIIPR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $198.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 6.22× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRNIIPR
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $198.2M | ||
| Q3 25 | $-12.7M | $45.6M | ||
| Q2 25 | $16.6M | $48.4M | ||
| Q1 25 | $-12.5M | $54.2M | ||
| Q4 24 | $-13.3M | $258.4M | ||
| Q3 24 | $-2.4M | $64.9M | ||
| Q2 24 | $-2.7M | $64.2M |
现金转化率AMRNIIPR
| Q1 26 | — | — | ||
| Q4 25 | — | 6.22× | ||
| Q3 25 | — | 1.56× | ||
| Q2 25 | — | 1.86× | ||
| Q1 25 | — | 1.75× | ||
| Q4 24 | — | 6.46× | ||
| Q3 24 | — | 1.61× | ||
| Q2 24 | -1.81× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
IIPR
暂无分部数据
